Corpus Intelligence IC Memo — CIRCLES OF CARE INC. 2026-04-27 01:02 UTC
IC Memo — CIRCLES OF CARE INC.
Investment Committee Memorandum | FL | 172 beds | Grade D | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 104024

CIRCLES OF CARE INC.

LOCATIONBREVARD, FL·BEDS172·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

CIRCLES OF CARE INC. is a 172-bed community hospital in BREVARD, FL with $26.2M in net patient revenue and a -85.9% operating margin. The hospital serves a payer mix of 4.6% Medicare, 0.0% Medicaid, and 95.4% commercial.

Thesis: Undervalued. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -85.9% to -78.6% (+736bps).

Net Revenue HCRIS$26.2M
Current EBITDA COMPUTED$-22.6M
Operating Margin COMPUTED-85.9%
Occupancy HCRIS51.0%
Revenue / Bed COMPUTED$153K
Net-to-Gross HCRIS44.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
121
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -85.9% places it below the state median. Among 121 size-comparable peers (86-344 beds), the median margin is 3.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (86-344), prioritizing same-state peers. 121 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CIRCLES OF CARE INC. (Target)FL172$26.2M-85.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%
CCF HOSPITAL - WESTONFL258$465.4M-3.8%
DELRAY MEDICAL CENTERFL324$453.3M12.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$551K+210bp18mo
Cost to Collect4.5%2.5%$525K+200bp12mo
Denial Rate Reduction12.0%6.5%$520K+198bp12mo
A/R Days Reduction5200.0%3800.0%$319K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$551K
Cost to Collect
$525K
Denial Rate Reduction
$520K
A/R Days Reduction
$319K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-22.6M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-20.6M
Current Margin-85.9%
Pro Forma Margin-78.6%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-34.7M$-129.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-34.7M$-153.7M0.00x-100.0%
Bull Case9.0x11.0x$-31.2M$-158.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-31.2M$-182.2M0.00x-100.0%
Bear Case11.0x10.0x$-38.2M$-127.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-38.2M$-153.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 121 hospitals with 86-344 beds
  • Same-state prioritization (n=122)
  • Comp margins: P25=-6.2% / P50=3.2% / P75=15.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.